- Home
- CLLS vs ASLE Comparison
CLLS vs ASLE Comparison
Compare CLLS & ASLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- ASLE
- Stock Information
- Founded
- CLLS 1999
- ASLE 2008
- Country
- CLLS France
- ASLE United States
- Employees
- CLLS N/A
- ASLE N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- ASLE Industrial Specialties
- Sector
- CLLS Health Care
- ASLE Consumer Discretionary
- Exchange
- CLLS Nasdaq
- ASLE Nasdaq
- Market Cap
- CLLS 299.0M
- ASLE 277.0M
- IPO Year
- CLLS 2007
- ASLE N/A
- Fundamental
- Price
- CLLS $2.96
- ASLE $8.72
- Analyst Decision
- CLLS Buy
- ASLE Hold
- Analyst Count
- CLLS 1
- ASLE 2
- Target Price
- CLLS $4.00
- ASLE $7.00
- AVG Volume (30 Days)
- CLLS 73.6K
- ASLE 495.8K
- Earning Date
- CLLS 11-03-2025
- ASLE 11-06-2025
- Dividend Yield
- CLLS N/A
- ASLE N/A
- EPS Growth
- CLLS N/A
- ASLE N/A
- EPS
- CLLS N/A
- ASLE 0.13
- Revenue
- CLLS $63,438,000.00
- ASLE $350,583,000.00
- Revenue This Year
- CLLS N/A
- ASLE $9.98
- Revenue Next Year
- CLLS $66.76
- ASLE $8.15
- P/E Ratio
- CLLS N/A
- ASLE $68.87
- Revenue Growth
- CLLS 223.09
- ASLE N/A
- 52 Week Low
- CLLS $1.10
- ASLE $4.53
- 52 Week High
- CLLS $3.35
- ASLE $9.12
- Technical
- Relative Strength Index (RSI)
- CLLS 63.19
- ASLE 61.26
- Support Level
- CLLS $2.53
- ASLE $8.16
- Resistance Level
- CLLS $3.35
- ASLE $8.72
- Average True Range (ATR)
- CLLS 0.16
- ASLE 0.29
- MACD
- CLLS 0.02
- ASLE -0.10
- Stochastic Oscillator
- CLLS 58.82
- ASLE 58.33
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About ASLE AerSale Corporation
AerSale Corp is an integrated, diversified leader in aviation aftermarket products and services. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing a broad range of maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. The company operating segment includes Asset Management Solutions and TechOps. It generates maximum revenue from the Asset Management Solutions segment.